265 related articles for article (PubMed ID: 25829091)
21. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S
J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
[TBL] [Abstract][Full Text] [Related]
22. (18)F-fluorodeoxyglucose positron emission tomography to assess response after radiation therapy in anaplastic thyroid cancer.
Levy A; Leboulleux S; Lepoutre-Lussey C; Baudin E; Ghuzlan AA; Hartl D; Deutsch E; Deandreis D; Lumbroso J; Tao Y; Schlumberger M; Blanchard P
Oral Oncol; 2015 Apr; 51(4):370-5. PubMed ID: 25595614
[TBL] [Abstract][Full Text] [Related]
23. Thyroid incidentalomas on FDG PET/CT in patients with non-thyroid cancer - a large retrospective monocentric study.
Kim H; Kim SJ; Kim IJ; Kim K
Onkologie; 2013; 36(5):260-4. PubMed ID: 23689220
[TBL] [Abstract][Full Text] [Related]
24. 18F-FDG PET in the management of patients with anaplastic thyroid carcinoma.
Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Kasperbauer JL; Reading CC; Hay ID; Lowe VJ
Thyroid; 2008 Jul; 18(7):713-9. PubMed ID: 18630999
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic utility of PETCT in thyroid malignancies: an update.
Palaniswamy SS; Subramanyam P
Ann Nucl Med; 2013 Oct; 27(8):681-93. PubMed ID: 23801405
[TBL] [Abstract][Full Text] [Related]
26. Designing and Developing PET-Based Precision Model in Thyroid Carcinoma: The Potential Avenues for a Personalized Clinical Care.
Basu S; Parghane RV
PET Clin; 2017 Jan; 12(1):27-37. PubMed ID: 27863564
[TBL] [Abstract][Full Text] [Related]
27. Soft tissue metastases from differentiated thyroid cancer diagnosed by ¹⁸F FDG PET-CT.
Califano I; Quildrian S; Coduti M; Rojas Bilbao E; Otero J; Califano L
Arq Bras Endocrinol Metabol; 2013 Jun; 57(4):317-21. PubMed ID: 23828437
[TBL] [Abstract][Full Text] [Related]
28. Fluorodeoxyglucose-PET/Computed Tomography-Guided Biopsy.
Cerci JJ; Tabacchi E; Bogoni M
PET Clin; 2016 Jan; 11(1):57-64. PubMed ID: 26590444
[TBL] [Abstract][Full Text] [Related]
29. Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas.
Sheikhbahaei S; Marcus C; Hafezi-Nejad N; Taghipour M; Subramaniam RM
PET Clin; 2015 Jul; 10(3):375-93. PubMed ID: 26099673
[TBL] [Abstract][Full Text] [Related]
30. Positron Emission Tomography/Computed Tomography in Thyroid Cancer: An Updated Review.
Chandekar KR; Satapathy S; Bal C
PET Clin; 2024 Apr; 19(2):131-145. PubMed ID: 38212213
[TBL] [Abstract][Full Text] [Related]
31. Role of Fluorodeoxyglucose PET/Computed Tomography in Targeted Radionuclide Therapy for Endocrine Malignancies.
Pattison DA; Hofman MS
PET Clin; 2015 Oct; 10(4):461-76. PubMed ID: 26384593
[TBL] [Abstract][Full Text] [Related]
32. Applications of Fluorodeoxyglucose PET/Computed Tomography in the Assessment and Prediction of Radiation Therapy-related Complications.
Houshmand S; Boursi B; Salavati A; Simone CB; Alavi A
PET Clin; 2015 Oct; 10(4):555-71. PubMed ID: 26384600
[TBL] [Abstract][Full Text] [Related]
33. PET/Computed Tomography in Neuroendocrine Tumor: Value to Patient Management and Survival Outcomes.
Shamim SA; Kumar A; Kumar R
PET Clin; 2015 Jul; 10(3):411-21. PubMed ID: 26099675
[TBL] [Abstract][Full Text] [Related]
34. Detection of thyroid cancer by an FDG-PET cancer screening program: a Japanese nation-wide survey.
Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
Anticancer Res; 2014 Aug; 34(8):4439-45. PubMed ID: 25075083
[TBL] [Abstract][Full Text] [Related]
35. Cervix carcinoma and incidental finding of medullary thyroid carcinoma by 18F-FDG PET/CT--clinical case.
Chaushev B; Bochev P; Klisarova A; Yordanov K; Encheva E; Dancheva J; Yordanova C; Hristozov K; Krasnaliev I; Radev R; Nenkov R
Nucl Med Rev Cent East Eur; 2014; 17(2):97-100. PubMed ID: 25088110
[TBL] [Abstract][Full Text] [Related]
36. Hybrid SPECT-CT and PET-CT imaging of differentiated thyroid carcinoma.
Wong KK; Zarzhevsky N; Cahill JM; Frey KA; Avram AM
Br J Radiol; 2009 Oct; 82(982):860-76. PubMed ID: 19433487
[TBL] [Abstract][Full Text] [Related]
37. PET imaging for thyroid cancers: Current status and future directions.
Giraudet AL; Taïeb D
Ann Endocrinol (Paris); 2017 Feb; 78(1):38-42. PubMed ID: 27989550
[TBL] [Abstract][Full Text] [Related]
38. (18)F-Flourodeoxy-Glucose PET/Computed Tomography in Brain Tumors: Value to Patient Management and Survival Outcomes.
Wray R; Solnes L; Mena E; Meoded A; Subramaniam RM
PET Clin; 2015 Jul; 10(3):423-30. PubMed ID: 26099676
[TBL] [Abstract][Full Text] [Related]
39. Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas.
Are C; Hsu JF; Ghossein RA; Schoder H; Shah JP; Shaha AR
Ann Surg Oncol; 2007 Nov; 14(11):3210-5. PubMed ID: 17713821
[TBL] [Abstract][Full Text] [Related]
40. Focal thyroid incidentaloma on whole body fluorodeoxyglucose positron emission tomography/computed tomography in known cancer patients: A case-based discussion with a series of three examples.
Targe M; Basu S
J Cancer Res Ther; 2015; 11(4):1029. PubMed ID: 26881609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]